Health Insurance Innovations Inc (NASDAQ:HIIQ) major shareholder Michael W. Kosloske sold 309,550 shares of Health Insurance Innovations stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $18.33, for a total value of $5,674,051.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
HIIQ stock opened at $20.11 on Wednesday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 1.36. The company has a market capitalization of $255.39 million, a price-to-earnings ratio of 10.93 and a beta of 1.38. Health Insurance Innovations Inc has a 12 month low of $15.95 and a 12 month high of $46.60. The firm has a 50 day moving average of $23.39 and a two-hundred day moving average of $23.09.
Health Insurance Innovations (NASDAQ:HIIQ) last released its quarterly earnings results on Tuesday, November 12th. The financial services provider reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.52. Health Insurance Innovations had a net margin of 3.93% and a return on equity of 29.73%. The business had revenue of $75.27 million for the quarter, compared to the consensus estimate of $91.23 million. During the same quarter last year, the firm earned $0.61 EPS. Health Insurance Innovations’s revenue for the quarter was up 5.3% on a year-over-year basis. On average, research analysts expect that Health Insurance Innovations Inc will post 3.49 EPS for the current fiscal year.
Several equities analysts have recently issued reports on HIIQ shares. Lake Street Capital reaffirmed a “buy” rating and issued a $50.00 price objective (up previously from $40.00) on shares of Health Insurance Innovations in a research note on Wednesday, November 13th. Cantor Fitzgerald reiterated a “buy” rating and issued a $80.00 price objective on shares of Health Insurance Innovations in a research note on Tuesday, November 26th. Craig Hallum cut their target price on shares of Health Insurance Innovations from $65.00 to $50.00 and set a “buy” rating for the company in a research report on Tuesday, August 6th. BidaskClub raised shares of Health Insurance Innovations from a “strong sell” rating to a “sell” rating in a research note on Saturday. Finally, Zacks Investment Research raised shares of Health Insurance Innovations from a “sell” rating to a “hold” rating in a research note on Tuesday, November 19th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $49.86.
Health Insurance Innovations Company Profile
Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provide 3 months to 12 months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer fixed cash benefits and additional benefits for procedures and services; and supplemental insurance products, including life insurance policies, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and pharmacy benefit cards.
See Also: Retained Earnings
Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.